scispace - formally typeset
N

Nigel M. Hooper

Researcher at Manchester Academic Health Science Centre

Publications -  305
Citations -  23253

Nigel M. Hooper is an academic researcher from Manchester Academic Health Science Centre. The author has contributed to research in topics: Amyloid precursor protein & Angiotensin-converting enzyme. The author has an hindex of 74, co-authored 299 publications receiving 21146 citations. Previous affiliations of Nigel M. Hooper include University of Cape Town & University of Virginia.

Papers
More filters
Journal ArticleDOI

A Human Homolog of Angiotensin-converting Enzyme CLONING AND FUNCTIONAL EXPRESSION AS A CAPTOPRIL-INSENSITIVE CARBOXYPEPTIDASE

TL;DR: A novel human zinc metalloprotease that has considerable homology to human angiotensin-converting enzyme (ACE) (40% identity and 61% similarity) has been identified.
Journal ArticleDOI

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

Paul Hollingworth, +177 more
- 01 May 2011 - 
TL;DR: Meta-analyses of all data provided compelling evidence that ABCA7 and the MS4A gene cluster are new Alzheimer's disease susceptibility loci and independent evidence for association for three loci reported by the ADGC, which, when combined, showed genome-wide significance.
Journal ArticleDOI

Families of zinc metalloproteases

TL;DR: A scheme based on the zinc binding site has been extended to classify zinc metalloproteases into distinct families, defined by the HEXXH motif and a glutamic acid as the third zinc ligand.
Journal ArticleDOI

Membrane protein secretases

TL;DR: Current knowledge of the various secretases are compared in this Review, and strategies for cell-free assays of such proteases are outlined as a prelude to their ultimate purification and cloning.
Journal ArticleDOI

Tumor necrosis factor-α convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)

TL;DR: Direct evidence is provided for the involvement of ADAM17 in the regulated ectodomain shedding of ACE2 by using inhibitors with differing potency toward different members of the ADAM (a disintegrin and metalloproteinase) family of proteases.